Plant-Based Complex Coacervates for Nutraceutical Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nutraceutical formulations face challenges in stability, efficacy, and consumer acceptability due to the susceptibility of Aframomum melegueta to oxidation and the volatile nature of its bioactive compounds, and there is a need for plant-based alternatives that replicate the properties of gelatin in coacervation processes.
Innovation Solution
A complex coacervate formulation using a plant extract mixed with a first polysaccharide and a plant protein, specifically pea protein and low-methoxy pectin, forms a sponge-like structure that encapsulates Aframomum melegueta, enhancing stability and efficacy while being compatible with diverse dietary preferences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If gelatin is used as the primary protein component in coacervate formulations, then ease of use and process efficiency are improved, but allergenic potential increases and compatibility with plant-based dietary preferences is reduced
Solution Approach 1:
The patent changes the chemical and physical parameters of the protein component by replacing gelatin with plant-based proteins (pea, soy, rice, hemp). This substitution maintains the essential functional properties (electrostatic charge, amphiphilic character, gelation behavior) while altering the source material to eliminate allergens and accommodate plant-based dietary preferences, thus resolving the contradiction between ease of use and dietary compatibility
Solution Approach 2:
The patent creates a copy of gelatin's functional properties using plant-based proteins. The plant proteins are selected and processed to replicate gelatin's key characteristics including its ability to form reversible gels, provide appropriate electrostatic charge for complex coacervation, and exhibit amphiphilic behavior. This copying approach maintains process efficiency while achieving dietary compatibility
2Adaptability or versatility
If plant-based proteins are used to replace gelatin, then allergenic potential is reduced and compatibility with dietary preferences is improved, but stability and gelation properties deteriorate
Solution Approach 1:
The patent employs composite material strategies by combining plant-based proteins with specific polysaccharides (alginate, carrageenan, pectin, guar gum, xanthan gum) to create a coacervate system that achieves both dietary compatibility and stability. The interactions between the plant protein and polysaccharide components create a synergistic effect that maintains the structural integrity, electrostatic balance, and gelation properties necessary for stable coacervate formation, thus resolving the contradiction between plant-based composition and stability
3Device complexity
If traditional single polysaccharide and protein combination is used, then formulation simplicity is maintained, but stability and compatibility with diverse dietary preferences are reduced
Solution Approach 1:
The patent applies multi-functionality by selecting polysaccharides and plant proteins that can serve multiple roles within the coacervate system. The chosen biopolymers simultaneously provide structural framework, electrostatic charge for complex coacervation, gelation capability, and stability under varying conditions. This multi-functional approach allows the formulation to achieve enhanced stability and dietary compatibility without proportionally increasing complexity, as the same components fulfill multiple critical functions
4Quantity of substance
If Aframomum melegueta extract is used directly without encapsulation, then bioactive compound availability is maximized, but susceptibility to oxidation and volatility lead to loss of efficacy
Solution Approach 1:
The patent uses the coacervate droplets as flexible shell structures to encapsulate the Aframomum melegueta extract. The biopolymer matrix forms a protective thin film around the bioactive compounds, creating a physical barrier that shields them from oxidation and reduces volatility. This encapsulation approach maintains high bioactive compound availability while protecting against harmful environmental factors, thus resolving the contradiction between accessibility and stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The complex coacervate system improves the encapsulation efficiency and stability of bioactive compounds, maintaining potency and efficacy over extended periods, and facilitates easier handling and processing, making it suitable for nutraceutical applications.
Implementation Method 1
Complex coacervates are colloidal systems formed through the interaction of oppositely charged polyelectrolytes
Implementation Method 2
Two oppositely charged polyelectrolytes, such as DNA, proteins or polysaccharides, interact with each other forming a dense network. The electrostatic polyelectrolyte-polyelectrolyte interaction leads to an almost neutral charge
Implementation Method 3
Coacervation is a phenomenon of liquid/liquid spontaneous phase separation leading to colloid-rich and colloid-poor phases
Implementation Method 4
the pectin and protein at least partially cover the first polysaccharide, and wherein the microcapsule has a size comprised between 1 and 200 μm
Data Source
Figure 1(a)~1(c)
Figure 2aA~2aD
Figure 2bA~2bD
AI summary
The present invention refers to nutraceutical compositions, to plant extracts and complex coacervates comprising them. The present invention further refers to uses thereof.